NfL as a biomarker for neurodegeneration and survival in Parkinson

Por um escritor misterioso
Last updated 18 maio 2024
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
Serum neurofilament light chain levels at attack predict post
NfL as a biomarker for neurodegeneration and survival in Parkinson
Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as
NfL as a biomarker for neurodegeneration and survival in Parkinson
Opinion: The Potential of Neurofilament Light Chain as a Biomarker
NfL as a biomarker for neurodegeneration and survival in Parkinson
A multicentre validation study of the diagnostic value of plasma
NfL as a biomarker for neurodegeneration and survival in Parkinson
Frontiers Neurofilament Proteins as Biomarkers to Monitor
NfL as a biomarker for neurodegeneration and survival in Parkinson
IJMS, Free Full-Text
NfL as a biomarker for neurodegeneration and survival in Parkinson
Neurofilament light chain
NfL as a biomarker for neurodegeneration and survival in Parkinson
Did you know there's a new biomarker for Parkinson's disease
NfL as a biomarker for neurodegeneration and survival in Parkinson
Association between plasma neurofilament light chain levels and

© 2014-2024 miaad.org. All rights reserved.